Peter Van Vlasselaer
InvestorFounderVenture Partner at +ND Capital · Board director at Blade Therapeutics
FoundedBlade Therapeutics
About
Peter joined +ND Capital in 2019 and was previously founder and CEO of ARMO Biosciences (acquired by Eli Lilly). He has led and co-founded multiple biotech companies and holds a PhD in Immunology.
Board director at Blade Therapeutics
Intro paths
→
In turn, Peter can intro founders to Blade Therapeutics's investors below.
Blade Therapeutics's investors · 5
Co-founders at Blade Therapeutics
WR
Wendye RobbinsExecutive Officer, Director
Deals · 2
RgenixBoard seat
via +ND Capital · filed Feb 2021 · $11M raise
Blade TherapeuticsBoard seat
via +ND Capital · filed Oct 2019 · $50M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at +ND Capital
Aditya Rajagopal
Venture Partner at +ND Capital
Alison Palmer
Vice President of the General Partner at +ND Capital
André Châtelain
Advisor at +ND Capital
Aymeric Sallin
Founder and CEO at +ND Capital
Carl Pabo
Advisor at +ND Capital
Cathleen O’Connor
Executive Assistant at +ND Capital
Eric Moessinger
Partner at +ND Capital
Gabriela Ecco
Principal at +ND Capital
Frequently asked questions
- Where does Peter Van Vlasselaer work?
- Peter Van Vlasselaer is Venture Partner at +ND Capital and Founder at Blade Therapeutics.
- What companies did Peter Van Vlasselaer found?
- Peter Van Vlasselaer founded Blade Therapeutics.